share_log

Bank7 Analyst Ratings

Bank7アナリストの評価

Benzinga ·  2023/10/30 12:05
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/30/2023 30.5% Piper Sandler $32 → $27 Maintains Overweight
10/27/2023 16% Stephens & Co. $27 → $24 Maintains Equal-Weight
05/01/2023 49.83% Piper Sandler $36 → $31 Maintains Overweight
09/16/2022 54.66% Piper Sandler $31 → $32 Maintains Overweight
09/30/2020 -37.17% Piper Sandler $13.5 → $13 Maintains Overweight
07/29/2020 -34.75% Piper Sandler $13 → $13.5 Maintains Overweight
05/04/2020 -42% Piper Sandler $11 → $12 Maintains Overweight
05/01/2020 -32.33% Stephens & Co. $15 → $14 Maintains Overweight

What is the target price for Bank7 (BSVN)?

The latest price target for Bank7 (NASDAQ: BSVN) was reported by Piper Sandler on October 30, 2023. The analyst firm set a price target for $27.00 expecting BSVN to rise to within 12 months (a possible 30.50% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Bank7 (BSVN)?

The latest analyst rating for Bank7 (NASDAQ: BSVN) was provided by Piper Sandler, and Bank7 maintained their overweight rating.

When is the next analyst rating going to be posted or updated for Bank7 (BSVN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bank7, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bank7 was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.

Is the Analyst Rating Bank7 (BSVN) correct?

While ratings are subjective and will change, the latest Bank7 (BSVN) rating was a maintained with a price target of $32.00 to $27.00. The current price Bank7 (BSVN) is trading at is $20.69, which is out of the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする